ABOUT BE BIOSOL | BIOLOGICAL E. LIMITED
For more than seven decades, Biological E has played an important role in improving global health through innovation, manufacturing excellence and access to life-saving products. Biosol represents the next phase of this journey—bringing together Biological E’s proven manufacturing foundation with new investments in biologics, advanced therapeutics and future-ready development platforms.
CONTACT INFORMATION
BE BioSol | Biological E. Limited
Biological E. Limited Road No. 35, Jubilee Hills Hyderabad
Telangana, 500033
INDIA
SOLUTIONS
-
BE Biosol provides integrated development and manufacturing services across biologics, vaccines and complex injectable products.
-
Biological E supports development and manufacturing of complex injectable products.
-
Biosol is expanding its biologics portfolio to include future capabilities in antisense oligonucleotide and siRNA technologies.
-
Designed for highly potent compounds, the platform supports ADC development from early-stage research through GMP manufacturing and commercial scale-up.
-
Biosol is establishing a comprehensive monoclonal antibody platform designed to support programs from development through commercial manufacturing.
-
Supplying products to 140+ countries and delivering billions of doses worldwide, Biosol provides integrated drug substance, drug product, fill-finish, and supply capabilities.
-
A multi-site manufacturing network supporting vaccines, biologics and specialty injectables—with significant infrastructure expansion planned through 2029.
-
Backed by Biological E’s proven quality systems and regulatory expertise, Biosol helps ensure product quality, process consistency, and compliance across programs.